Battersea Biotech

Battersea Biotech Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Battersea Biotech General Information


Provider of healthcare technology intended to develop cell therapies to treat cancer. The company's technology develops advanced techniques to overcome the shortcomings of current CAR-T and TCR technologies, enabling healthcare practitioners to provide proper treatment for cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 1700 Owens Street
  • Suite 530
  • San Francisco, CA 94107
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Battersea Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 21-Nov-2016 Completed Startup

Battersea Biotech Board Members (1)

Name Representing Role Since
Simeon George MD Self Board Member 000 0000

Battersea Biotech Investors (1)

To view Battersea Biotech‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial